Author:
Bachelard Hélène,Charest-Morin Xavier,Marceau François
Funder
Canadian Institutes of Health Research
Fonds de Recherche du Québec - Santé
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.;Araujo;Biochemistry,2000
2. Bradykinin B2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.;Bachvarov;J. Pharmacol. Exp. Ther.,2001
3. B-9972 (D-Arg-[Hyp3, Igl5, Oic7, Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, Igl5, D-Igl7, Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.;Bawolak;J. Pharmacol. Exp. Ther.,2007
4. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo.;Bouthillier;Br. J. Pharmacol.,1987
5. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.;Brown;Circulation,2000
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献